AMNY Group

Calling Houston Area Nonprofits-Register for our upcoming focus group on Economic Mobility.

Economic Mobility Focus Group for Nonprofits Help us better understand the landscape, partners and opportunities that improve economic mobility for our youth!

AMNY Consulting Group is conducting focus group research for the Greater Houston Community Foundation's High Impact Grantmaking initiative. Our next focus group topic area is Economic Mobility. We invite parents and residents who live in the Greater Houston area and want to share barriers you have faced to achieve financial stability for yourselves and your children, to register. See flyer for details. Note: Slots are limited. Preregistration is required to receive a confirmation email from AMNY Group that you have been selected to participate. No onsite registration is permitted.

AMNY Consulting Group is conducting research for Greater Houston Community Foundation's High Impact Grantmaking initiative. We are facilitating focus groups on 3 different issue areas: Early Childhood, Economic Mobility, and Youth Mental Health. You must live in the greater Houston area to participate (registration applications are reviewed and confirmation information sent by AMNY to selected participants). See flyer on our first event (virtual).

Because many I know and love suffer and have suffered from this debilitating disease, our AMNY Friday Feature (back from a short summer vacation hiatus) shares the announcement that the FDA U.S. Food and Drug Administration has approved Biogen's Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. While this is not an endorsement of the drug, it is a note of appreciation that medical research is advancing in this area: https://lnkd.in/g_C_2vpw

FDA Grants Accelerated Approval for Alzheimer’s Disease Treatment The FDA approved Leqembi (lecanemab-irmb), the second of a new category of medications approved for Alzheimer’s disease that target the fundamental pathophysiol